Considering the literature with the old nomenclature of NAFLD, Mantovani et al. [21] showed in their observational study that the severity of the adiponectin decrease is related to the degree of steatosis in T2DM, further directly affecting the stiffness of the liver parenchyma. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.